Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04844021 · ClinicalTrials.gov registry record · NA
Adolescent and Child Suicide Prevention in Routine Clinical Encounters
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 47,307
- Enrollment target
NCT04844021: Completed NA study, sponsored by Northwestern University.
NCT04844021 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 47,307 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3272% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04844021, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 47,307 participants
- Enrollment target
Study Summary
The objective of this study is to compare two approaches to implement an evidence-based firearm safety promotion program, S.A.F.E. Firearm, in pediatric primary care as a universal suicide prevention strategy. The first implementation approach is a prompt in the electronic health record (EHR; Nudge) reminding clinicians to a) discuss firearm storage and b) offer a free cable firearm lock during the pediatric well visit. The second implementation approach (Nudge+) includes both the EHR Nudge described above plus one year of support to the clinics in deploying the program (i.e., practice facilitation). The study also aims to identify how these strategies work and whether the S.A.F.E. Firearm program results in reduced unauthorized access to firearms by young people. The investigators hypothesize that a greater proportion of well-visits will have S.A.F.E. Firearm delivery documented in the electronic health record in Nudge+ clinics vs. Nudge clinics.
Primary Outcome
Reach is the proportion of eligible well-child visits who received the S.A.F.E. Firearm program. "Participants" refers to well-child visits. For each well-child visit, data regarding S.A.F.E. Firearm delivery were available in the form of binary indicators, with 1 indicating S.A.F.E. Firearm was delivered during the visit and 0 indicating S.A.F.E. Firearm was not delivered during the visit. Reach outcomes presented below are means of the binary indicators, which were calculated across all eligib
Interventions
- BEHAVIORAL Nudge
- BEHAVIORAL Nudge+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47,307 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2024-05-08 |
| Phase | NA |
What the finished NCT04844021 record still lists
NCT04844021 is an interventional study that assigns participants to a tested intervention. Its 47,307 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3272% higher).
The record links to 0 conditions, and to 2 interventions - of which Nudge is the first listed.
NCT04844021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04844021 about?
NCT04844021 is a clinical study titled "Adolescent and Child Suicide Prevention in Routine Clinical Encounters". The objective of this study is to compare two approaches to implement an evidence-based firearm safety promotion program, S.A.F.E. Firearm, in pediatric primary care as a universal suicide prevention strategy. The first implementation approach is a prompt in the electronic health record (EHR; Nudge)...
What is the current status of trial NCT04844021?
This trial is currently completed. It is a NA study. The enrollment target is 47,307 participants. The study started on 2022-03-14. Estimated completion is 2024-05-08.
What interventions are being tested in trial NCT04844021?
The interventions under investigation include: Nudge (BEHAVIORAL), Nudge+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT04844021?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04844021's enrollment target sits among peer trials
47,307 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03977402 · 47,500 participants
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
- NCT06655974 · 48,000 participants · NA
Predictive Modeling for Social Needs in Emergency Department Settings
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI